Mark Baldry
CIK 1644137 · Chief Commercial Officer · last filed 2025-06-03
Mark Baldry is a Chief Commercial Officer who has filed 11 SEC Form 4 insider transactions across 3 companies since 2015. The most recent filing shows the insider was granted $2.6K of XFOR on Jun 3, 2025. Across all open-market trades the lifetime net is −$5.4K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $330.3K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$330.3K
3
11
-$5.4K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| XFOR | Chief Commercial Officer | 25,337 | $4.00 | $101.3K | -$5.4K | 9 | 2025-06-03 |
| WVE | Chief Commerical Officer | 39,000 | $5.87 | $228.9K | $0 | 1 | 2019-08-07 |
| AMICUS THERAPEUTICS, INC. (FOLD) Delisted | VP Global Marketing | 25,000 | $14.49 | $362.2K | $0 | 1 | 2015-06-04 |
Recent Filings
11 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-06-03 | XFOR | Grant (A) | +1,032 | $2.6K | EDGAR |
| 2025-05-20 | XFOR | Buy (P) | +1,032 | $2.6K | EDGAR |
| 2025-02-14 | XFOR | Mixed | +635,050 | $19.3K | EDGAR |
| 2025-01-27 | XFOR | Mixed | +45,614 | -$13.2K | EDGAR |
| 2024-10-08 | XFOR | Mixed | +23,819 | -$6.5K | EDGAR |
| 2024-02-16 | XFOR | Grant (A) | — | $0 | EDGAR |
| 2023-11-03 | XFOR | Sell (S) | −10,257 | -$7.5K | EDGAR |
| 2023-11-02 | XFOR | Grant (A) | +34,947 | $0 | EDGAR |
| 2022-11-04 | XFOR | Grant (A) | — | $0 | EDGAR |
| 2019-08-07 | WVE | Grant (A) | +39,000 | $0 | EDGAR |